Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.

BMC cancer - 25 Aug 2016

Kubeček Ondřej, Soukup Tomáš, Paulík Adam, Kopecký Jindřich

Abstract excerpt

BACKGROUND: Dermatomyositis is an autoimmune myopathy characterized by proximal muscle weakness, muscle inflammation, and typical skin findings. It is a rare disease with an incidence of ~1/100 000. About 15-30 % of adult-onset cases are caused by underlying malignancy and dermatomyositis can be the first symptom of undiagnosed cancer, mainly in the case of anti-transcription intermediary factor 1γ (anti-TIF-1γ)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Biopsy
Share to Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Nodes

Share to Positron Emission Tomography Computed Tomography

Share to Transcription Factors

Share to Treatment Outcome

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 27561848
DOI: 10.1186/s12885-016-2715-1
PMCID: PMC5000476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.PMID 27561848Read ↗

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literatureSemantic proximity Read ↗

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside.Semantic proximity Read ↗

Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer–myositis connectionSemantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients.Semantic proximity Read ↗

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesSemantic proximity Read ↗

Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in dermatomyositis patients with anti-TIF1γ autoantibodiesSemantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Anti-melanoma-associated Antigen A1 Autoantibodies Predict the Outcome of Patients With Idiopathic Inflammatory Myopathies Related Interstitial Lung DiseaseSemantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.Semantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.